Carolan CG, Dillon GP, Khan D, Ryder SA, Gaynor JM, Reidy S, Marquez JF, Jones M, Holland V, Gilmer JF (2010) <br />Isosorbide-2-benzyl carbamate-5-salicylate, a peripheral anionic site binding subnanomolar selective butyrylcholinesterase inhibitor<br /><i>Journal of Medicinal Chemistry</i> <b>53</b>: 1190<br /><br />Dillon GP, Gaynor JM, Khan D, Carolan CG, Ryder SA, Marquez JF, Reidy S, Gilmer JF (2010) <br />Isosorbide-based cholinesterase inhibitors; replacement of 5-ester groups leading to increased stability<br /><i>Bioorganic & Medicinal Chemistry</i> <b>18</b>: 1045<br /><br />Carolan CG, Gaynor JM, Dillon GP, Khan D, Ryder SA, Reidy S, Gilmer JF (2008) <br />Novel isosorbide di-ester compounds as inhibitors of acetylcholinesterase<br /><i>Chemico-Biological Interactions</i> <b>175</b>: 293<br /><br />Khan D, Gilmer JF, Carolan CG, Gaynor JM, Ryder SA (2008) <br />Pharmacological effects of a novel isosorbide-based butyrylcholinesterase inhibitor<br /><i>Chemico-Biological Interactions</i> <b>175</b>: 231<br /><br />Gilmer JF, Murphy MA, Shannon JA, Breen CG, Ryder SA, Clancy JM (2003) <br />Single oral dose study of two isosorbide-based aspirin prodrugs in the dog<br /><i>J Pharm Pharmacol</i> <b>55</b>: 1351<br /><br />